Positive results with SGLT2 inhibitor in patients with diabetic kidney disease across all levels of eGFR - PACE-CME

Positive results with SGLT inhibitor in patients with diabetic kidney disease across all levels of eGFR

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Definition and Staging of CKM Syndrome
Definition and Staging of CKM Syndrome
MinuteCE®
Definition and Staging of CKM Syndrome
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
1.00 program credit
Screening for CKM Syndrome
Screening for CKM Syndrome
MinuteCE®
Screening for CKM Syndrome
1.00 program credit
- Jürgen Floege, MD
1.00 program credit
Comprehensive Management of Individuals with CKM Syndrome
Comprehensive Management of Individuals with CKM Syndrome
MinuteCE®
Comprehensive Management of Individuals with CKM Syndrome
1.00 program credit
- Muthiah Vaduganathan, MD
1.00 program credit